
Validea's guru fundamental report assigned McKesson Corp (MCK), a large-cap growth stock in the Major Drugs industry, a 100% rating from the Pim van Vliet Multi-Factor Investor model. This top score indicates strong interest based on MCK's underlying fundamentals and valuation, aligning with a strategy that emphasizes low volatility stocks for potentially superior risk-adjusted returns.
McKesson Corp (MCK) has been assigned a perfect 100% rating by Validea's Multi-Factor Investor model, which emulates the conservative factor strategy of Pim van Vliet. This top-tier score indicates strong quantitative appeal for the large-cap drug company, whose profile aligns with the model's search for low-volatility stocks that have historically delivered superior risk-adjusted returns. According to the strategy's specific criteria, MCK passes on market capitalization and, critically, on its low standard deviation, directly confirming the low-risk characteristic central to the thesis. Interestingly, the stock registers a "NEUTRAL" score for both its "Twelve Minus One Momentum" and "Net Payout Yield." Despite these neutral factors, the model's final rank is a "PASS" with a 100% score, suggesting that the stock's strong defensive attributes and size are the dominant drivers of its appeal within this specific quantitative framework.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.85
Ticker Sentiment